Conjunctivitis Treatment Market, Global Outlook and Forecast 2022-2028

April 2022 | 67 pages | ID: CA6B7CC93C15EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Conjunctivitis Treatment in Global, including the following market information:

Global Conjunctivitis Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Conjunctivitis Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Antibiotic Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Conjunctivitis Treatment include Allergan, Inc, Merck, Pfizer, Inc. and Novartis, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Conjunctivitis Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Conjunctivitis Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Conjunctivitis Treatment Market Segment Percentages, by Type, 2021 (%)

• Antibiotic
• Pills
• Ointment

Global Conjunctivitis Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Conjunctivitis Treatment Market Segment Percentages, by Application, 2021 (%)

• Newborns
• Children
• Adults

Global Conjunctivitis Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Conjunctivitis Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Conjunctivitis Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Conjunctivitis Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Allergan, Inc
• Merck
• Pfizer, Inc.
• Novartis

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Conjunctivitis Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Conjunctivitis Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL CONJUNCTIVITIS TREATMENT OVERALL MARKET SIZE

2.1 Global Conjunctivitis Treatment Market Size: 2021 VS 2028
2.2 Global Conjunctivitis Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Conjunctivitis Treatment Players in Global Market
3.2 Top Global Conjunctivitis Treatment Companies Ranked by Revenue
3.3 Global Conjunctivitis Treatment Revenue by Companies
3.4 Top 3 and Top 5 Conjunctivitis Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Conjunctivitis Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Conjunctivitis Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Conjunctivitis Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Conjunctivitis Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Conjunctivitis Treatment Market Size Markets, 2021 & 2028
  4.1.2 Antibiotic
  4.1.3 Pills
  4.1.4 Ointment
4.2 By Type - Global Conjunctivitis Treatment Revenue & Forecasts
  4.2.1 By Type - Global Conjunctivitis Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Conjunctivitis Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Conjunctivitis Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Conjunctivitis Treatment Market Size, 2021 & 2028
  5.1.2 Newborns
  5.1.3 Children
  5.1.4 Adults
5.2 By Application - Global Conjunctivitis Treatment Revenue & Forecasts
  5.2.1 By Application - Global Conjunctivitis Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Conjunctivitis Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Conjunctivitis Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Conjunctivitis Treatment Market Size, 2021 & 2028
6.2 By Region - Global Conjunctivitis Treatment Revenue & Forecasts
  6.2.1 By Region - Global Conjunctivitis Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Conjunctivitis Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Conjunctivitis Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Conjunctivitis Treatment Revenue, 2017-2028
  6.3.2 US Conjunctivitis Treatment Market Size, 2017-2028
  6.3.3 Canada Conjunctivitis Treatment Market Size, 2017-2028
  6.3.4 Mexico Conjunctivitis Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Conjunctivitis Treatment Revenue, 2017-2028
  6.4.2 Germany Conjunctivitis Treatment Market Size, 2017-2028
  6.4.3 France Conjunctivitis Treatment Market Size, 2017-2028
  6.4.4 U.K. Conjunctivitis Treatment Market Size, 2017-2028
  6.4.5 Italy Conjunctivitis Treatment Market Size, 2017-2028
  6.4.6 Russia Conjunctivitis Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Conjunctivitis Treatment Market Size, 2017-2028
  6.4.8 Benelux Conjunctivitis Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Conjunctivitis Treatment Revenue, 2017-2028
  6.5.2 China Conjunctivitis Treatment Market Size, 2017-2028
  6.5.3 Japan Conjunctivitis Treatment Market Size, 2017-2028
  6.5.4 South Korea Conjunctivitis Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Conjunctivitis Treatment Market Size, 2017-2028
  6.5.6 India Conjunctivitis Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Conjunctivitis Treatment Revenue, 2017-2028
  6.6.2 Brazil Conjunctivitis Treatment Market Size, 2017-2028
  6.6.3 Argentina Conjunctivitis Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Conjunctivitis Treatment Revenue, 2017-2028
  6.7.2 Turkey Conjunctivitis Treatment Market Size, 2017-2028
  6.7.3 Israel Conjunctivitis Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Conjunctivitis Treatment Market Size, 2017-2028
  6.7.5 UAE Conjunctivitis Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Allergan, Inc
  7.1.1 Allergan, Inc Corporate Summary
  7.1.2 Allergan, Inc Business Overview
  7.1.3 Allergan, Inc Conjunctivitis Treatment Major Product Offerings
  7.1.4 Allergan, Inc Conjunctivitis Treatment Revenue in Global Market (2017-2022)
  7.1.5 Allergan, Inc Key News
7.2 Merck
  7.2.1 Merck Corporate Summary
  7.2.2 Merck Business Overview
  7.2.3 Merck Conjunctivitis Treatment Major Product Offerings
  7.2.4 Merck Conjunctivitis Treatment Revenue in Global Market (2017-2022)
  7.2.5 Merck Key News
7.3 Pfizer, Inc.
  7.3.1 Pfizer, Inc. Corporate Summary
  7.3.2 Pfizer, Inc. Business Overview
  7.3.3 Pfizer, Inc. Conjunctivitis Treatment Major Product Offerings
  7.3.4 Pfizer, Inc. Conjunctivitis Treatment Revenue in Global Market (2017-2022)
  7.3.5 Pfizer, Inc. Key News
7.4 Novartis
  7.4.1 Novartis Corporate Summary
  7.4.2 Novartis Business Overview
  7.4.3 Novartis Conjunctivitis Treatment Major Product Offerings
  7.4.4 Novartis Conjunctivitis Treatment Revenue in Global Market (2017-2022)
  7.4.5 Novartis Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Conjunctivitis Treatment Market Opportunities & Trends in Global Market
Table 2. Conjunctivitis Treatment Market Drivers in Global Market
Table 3. Conjunctivitis Treatment Market Restraints in Global Market
Table 4. Key Players of Conjunctivitis Treatment in Global Market
Table 5. Top Conjunctivitis Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Conjunctivitis Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Conjunctivitis Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Conjunctivitis Treatment Product Type
Table 9. List of Global Tier 1 Conjunctivitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Conjunctivitis Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Conjunctivitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Conjunctivitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Conjunctivitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Conjunctivitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Conjunctivitis Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Conjunctivitis Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Conjunctivitis Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Conjunctivitis Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Conjunctivitis Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Conjunctivitis Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Conjunctivitis Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Conjunctivitis Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Conjunctivitis Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Conjunctivitis Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Allergan, Inc Corporate Summary
Table 31. Allergan, Inc Conjunctivitis Treatment Product Offerings
Table 32. Allergan, Inc Conjunctivitis Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Conjunctivitis Treatment Product Offerings
Table 35. Merck Conjunctivitis Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Pfizer, Inc. Corporate Summary
Table 37. Pfizer, Inc. Conjunctivitis Treatment Product Offerings
Table 38. Pfizer, Inc. Conjunctivitis Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Novartis Corporate Summary
Table 40. Novartis Conjunctivitis Treatment Product Offerings
Table 41. Novartis Conjunctivitis Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Conjunctivitis Treatment Segment by Type in 2021
Figure 2. Conjunctivitis Treatment Segment by Application in 2021
Figure 3. Global Conjunctivitis Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Conjunctivitis Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Conjunctivitis Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Conjunctivitis Treatment Revenue in 2021
Figure 8. By Type - Global Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 12. US Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 24. China Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Conjunctivitis Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Conjunctivitis Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Allergan, Inc Conjunctivitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Conjunctivitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Pfizer, Inc. Conjunctivitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Novartis Conjunctivitis Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)